In a younger group of patients with a complex phenotype including CVID, thrombocytopenia, psoriatic arthritis and enteropathy, the detection of a mutation in CTLA4 prompted us to treat them with abatacept, with benefits [41]. Here, CTLA4 is linked to Abnormal intestine morphology.